Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen V Liu

Showing results (71-80 of 187) with videos related to

Pageof 19
Sort By:
Annals of Translational Medicine|December 5, 2022
Classical <i>ALK</i> G1202R resistance mutation was identified in a lung adenocarcinoma patient with rare <i>LOC388942-ALK</i> fusion after sequential treatment with ALK-TKIs and anlotinib: a case reportXiaoqian Zhai, Yanyang Liu, Zuoyu Liang, et al.
JTO Clinical and Research Reports|October 3, 2022
Osimertinib and Capmatinib Combination Therapy to Overcome <i>MET</i> Y1003N-Mediated Resistance in <i>EGFR</i>-Mutant NSCLC: A Case ReportMolly Wilgucki, Vincent Yeung, Grace Ho, et al.
Translational Lung Cancer Research|April 23, 2021
Effect of prior therapy on tumor mutational burden in NSCLCSushma Jonna, Ari Vanderwalde, Jorge Nieva, et al.
Lung Cancer (Amsterdam, Netherlands)|January 14, 2024
Real-world outcomes associated with afatinib use in patients with solid tumors harboring NRG1 gene fusionsStephen V Liu, Claas Frohn, Lori Minasi, et al.
The Prostate|November 14, 2014
Effects of luteinizing hormone receptor signaling in prostate cancer cellsShigang Xiong, Qingcai Wang, Stephen V Liu, et al.
Cancers|April 3, 2021
Novel Cytotoxic Chemotherapies in Small Cell Lung CarcinomaDiego Cortinovis, Paolo Bidoli, Stefania Canova, et al.
Frontiers in Oncology|September 27, 2021
A Phase I Trial of Dasatinib and Osimertinib in TKI Naïve Patients With Advanced EGFR-Mutant Non-Small-Cell Lung CancerChul Kim, Stephen V Liu, Jennifer Crawford, et al.
JCO Precision Oncology|September 11, 2020
Response to Entrectinib in Differentiated Thyroid Cancer With a <i>ROS1</i> FusionStephen V Liu, Laura A Macke, Bradley S Colton, et al.
American Journal of Physiology. Cell Physiology|October 17, 2008
Rac1 promotes intestinal epithelial restitution by increasing Ca2+ influx through interaction with phospholipase C-(gamma)1 after woundingJaladanki N Rao, Stephen V Liu, Tongtong Zou, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 28, 2025
Comprehensive Genomic Profiling of Rare Lung Tumors: Adenosquamous Carcinoma and Pulmonary CarcinosarcomaTianhao Zhou, Olivia C Terry, Katherine G Minton, et al.
Pageof 19

Showing results (71-80 of 187) with videos related to

Sort By:
Pageof 19
Annals of Translational Medicine|December 5, 2022
Classical <i>ALK</i> G1202R resistance mutation was identified in a lung adenocarcinoma patient with rare <i>LOC388942-ALK</i> fusion after sequential treatment with ALK-TKIs and anlotinib: a case reportXiaoqian Zhai, Yanyang Liu, Zuoyu Liang, et al.
JTO Clinical and Research Reports|October 3, 2022
Osimertinib and Capmatinib Combination Therapy to Overcome <i>MET</i> Y1003N-Mediated Resistance in <i>EGFR</i>-Mutant NSCLC: A Case ReportMolly Wilgucki, Vincent Yeung, Grace Ho, et al.
Translational Lung Cancer Research|April 23, 2021
Effect of prior therapy on tumor mutational burden in NSCLCSushma Jonna, Ari Vanderwalde, Jorge Nieva, et al.
Lung Cancer (Amsterdam, Netherlands)|January 14, 2024
Real-world outcomes associated with afatinib use in patients with solid tumors harboring NRG1 gene fusionsStephen V Liu, Claas Frohn, Lori Minasi, et al.
The Prostate|November 14, 2014
Effects of luteinizing hormone receptor signaling in prostate cancer cellsShigang Xiong, Qingcai Wang, Stephen V Liu, et al.
Cancers|April 3, 2021
Novel Cytotoxic Chemotherapies in Small Cell Lung CarcinomaDiego Cortinovis, Paolo Bidoli, Stefania Canova, et al.
Frontiers in Oncology|September 27, 2021
A Phase I Trial of Dasatinib and Osimertinib in TKI Naïve Patients With Advanced EGFR-Mutant Non-Small-Cell Lung CancerChul Kim, Stephen V Liu, Jennifer Crawford, et al.
JCO Precision Oncology|September 11, 2020
Response to Entrectinib in Differentiated Thyroid Cancer With a <i>ROS1</i> FusionStephen V Liu, Laura A Macke, Bradley S Colton, et al.
American Journal of Physiology. Cell Physiology|October 17, 2008
Rac1 promotes intestinal epithelial restitution by increasing Ca2+ influx through interaction with phospholipase C-(gamma)1 after woundingJaladanki N Rao, Stephen V Liu, Tongtong Zou, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 28, 2025
Comprehensive Genomic Profiling of Rare Lung Tumors: Adenosquamous Carcinoma and Pulmonary CarcinosarcomaTianhao Zhou, Olivia C Terry, Katherine G Minton, et al.
Pageof 19